<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="21168">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02831322</url>
  </required_header>
  <id_info>
    <org_study_id>21735</org_study_id>
    <nct_id>NCT02831322</nct_id>
  </id_info>
  <brief_title>A Study of Structure and Function of Radial Artery After Transradial Coronary Intervention</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>The First Hospital of Qinhuangdao</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The First Hospital of Qinhuangdao</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Several approaches have been proposed to reduce the risk of RAO, including anticoagulation,
      immediate postprocedural sheath removal, and a small sheath/radial artery ratio. Doppler
      ultrasound examination showed that interrupted blood flow in RA tend to occur in the
      proximal end rather than distal part of the artery,which was ignored by a majority of
      interventional cardiologists. Different insights into occlusion location may lead to
      different options of sheath materials, models, catheters and puncture access. Thus, the
      investigators designed this present study to explore the reason of radial artery endothelial
      dysfuction and damage and occlusion location by ﬂow-mediated dilation (FMD) to determine the
      suitable method to reduce occlusion risk during TRI.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">August 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Investigator</masking>
  </study_design_info>
  <primary_outcome>
    <measure>radial artery occlusion</measure>
    <time_frame>6 month</time_frame>
    <description>radial artery occlusion was the absence of a flow signal by Doppler ultrasound examination</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Intervention</condition>
  <condition>Transradial</condition>
  <arm_group>
    <arm_group_label>radial artery occlusion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Radial artery occlusion was the absence of a flow signal by Doppler ultrasound examination.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>radial artery normal</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Radial artery normal was blood flow signal by Doppler ultrasound</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Percutaneous coronary intervention</intervention_name>
    <description>Percutaneous coronary intervention was a nonsurgical technique for treating obstructive coronary artery disease</description>
    <arm_group_label>radial artery occlusion</arm_group_label>
    <arm_group_label>radial artery normal</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  admitted for transradial catheterization.

        Exclusion Criteria:

          -  femoral access, arterial circulatory disease, pathological Allen tests, decompensated
             heart failure, chronic renal failure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>qingsheng wang, Master</last_name>
    <phone>+8613933512559</phone>
    <email>qswang335@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Qingsheng wang</name>
      <address>
        <city>Qinhuangdao</city>
        <state>Hebei</state>
        <zip>066000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Qingsheng wang, Master</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <lastchanged_date>March 17, 2017</lastchanged_date>
  <firstreceived_date>July 4, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Transradial</keyword>
  <keyword>ﬂow-mediated vasodilation</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
